Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20

Neuroscience

Volumn 71, Issue 4, 1996, Pages 1073-1081

  Tallent, M ^a   Liapakis, G ^a   O'Carroll, A M ^b   Lolait, S J ^b   Dichter, M ^a   Reisine, T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Calcium current; Neurotransmitter; Somatostatin; Somatostatin antagonist

Indexed keywords

BIM 23027; CYCLIC AMP; DEXTRO PHENYLALANYLPHENYLALANYLPHENYLALANYL DEXTRO TRYPTOPHYLLYSYLTHREONYLPHENYLALANYLTHREONINAMIDE; L 362855; L 372587; L 372588; NC8 12; RECEPTOR SUBTYPE; SEGLITIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR AGONIST; SOMATOSTATIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CHINESE HAMSTER; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; NONHUMAN; OVARY CELL; PATCH CLAMP; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL LINE; CHO CELLS; CRICETINAE; ION CHANNEL GATING; LIGANDS; PATCH-CLAMP TECHNIQUES; PEPTIDES, CYCLIC; PITUITARY GLAND; RATS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 0029930179     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00510-2     Document Type: Article

References (67)

1. Bell G. I. and Reisine T. (1993) Molecular biology of SRIF receptors. Trends Neurosci. 16, 34-38.
2. Bloom S., Mortimer C., Thorner M., Besser G., Hall R., Gomex-Pan A., Roy U., Russel R., Coy D., Kastin A. and Schally A. (1974) Inhibition of gastrin and gastric acid secretion by growth hormone release-inhibitory hormone. Lancet ii, 1106-1109.
3. Bloom S., Ralphs D., Besser G., Hall R., Coy D., Kastin A. and Schally A. (1975) Effect of SRIF on motilin levels and gastric emptying. Gut 16, 834.
4. Brazeau P., Vale W., Burgus R., Ling N., Rivier J. and Guillemin R. (1972) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 129, 77-79.
5. Breder C. D., Yamada Y., Yasuda K. and Seino S. and Saper C. B. and Bell G. I. (1992) Differential expression of SRIF receptor subtypes in brain. J. Neurosci. 12, 3920-3934.
6. Brown J. (1990) Octreotide: a long-acting somatostatin analog. Am. J. med. Sci. 300, 267-273.
7. Brown M., Rivier J., Vale W. (1977) SRIF analogs with selected biological activities. Science 196, 1467-1468.
8. Bruno J. F., Xu Y., Song J. and Berelowitz M. (1992) Molecular cloning and functional expression of a novel brain specific SRIF receptor. Proc. natn. Acad. Sci. U.S.A. 89, 11151-11155.
9. Bruno J.-F., Xu Y., Song J. and Berelowitz M. (1993) Tissue distribution of SRIF receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133, 2561-2567.
10. Buscail L., Delesque N., Esteve J.-P., Saint-Laurent N., Prats H., Clerc P., Robberecht D., Bell G. I., Liebow C., Schally A. V., Vaysse N. and Susini C. (1994) Stimulation of tyrosine phosphatase and inhibition of cell proliferation by SRIF analogues: mediation by human SRIF receptor subtypes SSTR1 and SSTR2. Proc. natn. Acad. Sci. U.S.A. 91, 2315-2319.
11. Buscail L., Esteve J. P., Saint-Laurent N., Bertrand V., Reisine T., O'Carroll A. M., Bell G. I., Schally A. and Vaysse N. and Susini, C. (1995) Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by SSTR2 and SSTR5 somatostatin receptor subtypes through different mechanisms. Proc. natn. Acad. Sci. U.S.A. 92, 1580-1584.
12. DeNoble V., Hepler D. and Barto R. (1989) Cystamine-induced depletion of SRIF produces differential cognitive deficits in rats. Brain Res. 428, 42-48.
13. Epelbaum J. (1986) SRIF in the central nervous system: physiology and pathological modification. Prog. Neurobiol. 27, 63-100.
14. Epelbaum J., Dournaud P., Fodor M. and Viollet C. (1994) The neurobiology of SRIF. Crit. Rev. Neurobiol. 8, 25-44.
15. Feniuk W., Dimech J. and Humphrey P. P. A. (1993) Characterization of SRIF receptors in guinea-pig isolated ileum, vas deferens and right atrium. Br. J. Pharmac. 110, 1156-1164.
16. Fujii Y., Gonoi T., Yamada Y., Chihara K., Inagaki N. and Seino S. (1994) Somatostatin receptor subtype SSTR2 mediates inhibition of high-voltage activated calcium channels by somatostatin and its analogue SMS 201-995, Fedn. Eur. biochem. Socs Lett. 355, 117-120.
17. Gomez-Pan A., Reed J., Albinus M., Shaw B., Hall R., Besser G., Coy D., Kastin A. and Schally A. (1975) Direct inhibition of gastric acid and pepsin secretion by growth-hormone release-inhibiting hormone in cats. Lancet i, 888-890.
18. Hamill O., Marty A., Neher E., Sakmann B. and Sigworth F. (1981) Improved patch-clamp technique for high resolution current recordings from cell and cell-free membrane patches. Pflügers Arch. 391, 85-100.
19. Haroutunian V., Mantin G., Campell G., Tsuboyama G. and Davis K. (1987) Cysteamine-induced depletion of central SRIF-like immunoreactivity: effects on behavior, learning, memory and brain neurochemistry. Brain Res. 403, 234-242.
20. 1 cells. Endocrinology 84, 1484-1488.
21. Hoyer D., Lubbert H. and Bruns C. (1994) Molecular pharmacology of somatostatin receptors. Naunyn-Schmiedeberg's Arch. Pharmac. 350, 441-453.
22. 2+ current in rat sympathetic ganglion neurons. J. Physiol. 409, 221-240.
23. Jakobs K., Aktories K. and Schultz G. (1983) A nucleotide regulatory site for SRIF inhibition of adenylyl cyclase in S49 lymphoma cells. Nature 303, 177-178.
24. Kleuss C., Hescheler J., Ewel C., Rosenthal W., Schultz G. and Wittig R. (1991) Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 353, 43-48.
25. Kubota A., Yamada Y., Kagimoto S., Shimatsu A., Imamura M., Tsuda K., Imura H., Seino S. and Seino Y. (1994) Identification of SRIF receptor subtypes and an implication for the efficacy of SRIF analog SMS 201-955 in treatment of human endocrine tumors. J. clin. Invest. 93, 1321-1325.
26. Lamberts S., Krenning E. and Reubi J.-C. (1991) The role of SRIF and its analogs in the diagnosis and treatment of tumors. Endocrine Rev. 12, 450-482.
27. Law S., Manning D. and Reisine T. (1991) Identification of the subunits of GTP binding proteins coupled to SRIF receptors. J. biol. Chem. 266, 17,885-17,897.
28. Law S. and Reisine T. (1992) Agonist binding to rat brain SRIF receptors alters the interaction of the receptor with guanine nucleotide binding regulatory proteins. Molec. Pharmac. 42, 398-402.
29. Law S., Woulfe D, and Reisine T. (1995) SRIF receptor activation of cellular effector systems. Minireview. Cell. Signalling 7, 1-8.
30. oa selectively associate with the cloned SRIF receptor subtype SSTR2. J. biol. Chem. 268, 10,721-10,727.
31. Lewis D., Weight F. F. and Luini A. (1986) A guanine nucleotide-binding protein mediates the inhibition of voltage-dependent calcium current by somatostatin on a pituitary cell line. Proc. natn. Acad. Sci. U.S.A. 83, 9035-9039.
32. Liebow C., Reilly C., Serrano M. and Schally A. (1989) SRIF analogues inhibit the growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. natn. Acad. Sci. U.S.A. 86, 2003-2007.
33. Luini A., Lewis D., Guild S., Schofield G. and Weight F. F. (1986) Somatostatin, an inhibitor of ACIH secretion, decreases cytosolic free calcium and voltage-dependent calcium current in a pituitary cell line. J. Neurosci. 6, 3128-3132.
34. Mahy N., Woolkalis M., Manning D. and Reisine T. (1988) Characteristics of somatostatin desensitization in the pituitary tumor cell line AtT-20. J. Pharmac. exp. Therap. 246, 779-785.
35. Mandarino L., Stenner D., Blanchard W., Nissen S., Gerich J., Ling N., Brazeau P., Bohlen P., Esch F. and Guillemin R. (1981) Selective effects of SRIF-14, -25, and -28 on in vitro insulin and glucagon secretion. Nature 291, 76-77.
36. 2+ current modulated by cGMP-dependent protein kinase. Nature 369, 336-339.
37. Mihara S., North R. and Suprenant A. (1987) SRIF increases an inwardly rectifying potassium conductance in guinea-pig submucous plexus neurons. J. Physiol. 390, 335-355.
38. Moore S., Madamba S., Joels M. and Siggins G. (1988) Somatostatin augments the M-current in hippocampal neurons. Science 239, 278-280.
39. O'Carroll A.-M., Lolait S. J., Konig M. and Mahan L. C. (1992) Molecular cloning and expression of a pituitary SRIF receptor with preferential affinity for SRIF-28. Molec. Pharmac. 42, 939-946.
40. O'Carroll, A.-M., Raynor K., Lolait S. J. and Reisine T. (1994) Characterization of cloned human SRIF receptor SSTR5. Molec. Pharmac. 48, 291-298.
41. Ozenberger, B. and Hadcock J. (1995) A single amino acid substitution in the somatostatin receptor subtype 5 increases affinity for SRIF 14. Molec. Pharmac. 47, 82-87.
42. Pan M., Florio T. and Stork P. (1992) G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 256, 1215-1217.
43. Patel Y., Panetta R., Escher E., Greenwood M. and Srikant C. (1994) Expression of multiple SRIF receptor genes in AtT-20 cells. J. biol. Chem. 269, 1506-1509.
44. Pradayrol L., Jornvall H., Mutt V. and Ribet A. (1980) N-terminally extended SRIF: the primary structure of SRIF-28. Fedn. Eur. biochem. Socs Lett. 109, 55-58.
45. Raynor K., Murphy W., Coy D., Taylor J., Moreau J.-P., Yasuda K., Bell G. I. and Reisine T. (1993) Cloned SRIF receptors: identification of subtype selective peptides and demonstration of high affinity binding of linear peptides. Molec. Pharmac. 43, 838-844.
46. Raynor K., O'Carroll A.-M., Kong FL, Yasuda K., Mahan L., Bell G. I. and Reisine T. (1993) Characterization of cloned SRIF receptors SSTR4 and SSTR5. Molec. Pharmac. 44, 385-392.
47. Raynor K. and Reisine T. (1992) SRIF receptors. Crit. Rev. Neurobiol. 16, 273-289.
48. Raynor K., Wang H., Dichter M. and Reisine T, (1991) Subtypes of brain SRIF receptors couple to multiple cellular effector systems. Molec. Pharmac. 40, 248-253.
49. Reichlin S. (1983) SRIF. New Engl. J. Med. 309, 1495-1563.
50. Reisine T. (1984) SRIF desensitization: loss of the ability of SRIF to inhibit cAMP accumulation and adrenocorticotropin release. J. Pharmac. Exp. Ther. 229, 14-20.
51. Reisine T. and Axelrod J. (1983) Prolonged SRIF pretreatment desensitizes SRIF inhibition of receptor-mediated release of adrenocorticotropin and sensitizes adenylyl cyclase. Endocrinology 113, 811-813.
52. Reisine T., Kong H., Raynor K., Yano H., Takeda J., Yasuda K. and Bell G. I. (1993) Splice variant of the SRIF receptor 2 subtype, SSTR2B, couples to adenylyl cyclase. Molec. Pharmac. 44, 1008-1015.
53. 2+ in stimulated and somatostatin-inhibited secretion. Endocrinology 113, 62-68.
54. Rossowski W. and Coy D. (1993) Potent inhibitory effects of a type four receptor selective SRIF analog on rat insulin release. Biochem. biophys. Res. Commun. 197, 366-371.
55. Rossowski W. and Coy D. (1994) Specific inhibition of rat pancreatic insulin and glucagon release by receptor-selective somatostatin analogs. Biochem. biophys. Res. Commun. 205, 341-346.
56. Rossowski W., Gu Z., Akarca U., Jensen R. and Coy D. C. (1994) Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase release. Peptides 15, 1421-1424.
57. Shaprio M. and Hille B. (1993) Substance P and somatostatin inhibit calcium channels in rat sympathetic neurons via different G protein pathways. Neuron 10, 11-20.
58. ial selectively couples SRIF receptor to adenylyl cyclase in the pituitary cell line AtT-20. Molec. Pharmac. 41, 452-455.
59. Theveniau M., Yasuda K., Bell G. I. and Reisine T. (1994) Immunological detection of isoforms of the SRIF receptor subtype, SSTR2. J. Neurochem. 63, 447-455.
60. Wang H., Bogen C., Reisine T. and Dichter M. (1989) SRIF-14 and SRIF-28 induce opposite effects on potassium currents in rat neocortical neurons. Proc. natn. Acad. Sci. U.S.A. 86, 9616-9620.
61. Wang H., Dichter M. and Reisine T. (1990) Lack of cross-desensitization of SRIF-14 and SRIF-28 receptors coupled to potassium channels in rat neocortical neurons. Molec. Pharmac. 38, 357-361.
62. Wang H., Reisine T. and Dichter M. (1990) SRIF-14 and SRIF-28 inhibit calcium currents in rat neocortical neurons. Neuroscience 38, 335-342.
63. + channels through protein phosphorylation. Nature 351, 570-573.
64. Yamada Y., Post S. R., Wang K., Tager H. S., Bell G. I. and Seino S. (1992) Cloning and functional characterization of a family of human and mouse SRIF receptors expressed in brain, gastrointestinal tract, and kidney. Proc. natn. Acad. Sci. U.S.A. 89, 251-255.
65. Yamada Y., Reisine T., Law S. F., Ihara Y., Kubota A., Kagimoto S., Seino M., Seino Y., Bell G. I. and Seino S. (1993) SRIF receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Molec. Endocrinol. 6, 2136-2142.
66. Yasuda K., Rens-Domiano S., Breder C. D., Law S. F., Saper C. B., Reisine T. and Bell G. I. (1992) Cloning of a novel SRIF receptor, SSTR3, that is coupled to adenylyl cyclase. J. biol. Chem. 267, 20,422-20,428.
67. k protein in clonal rat anterior pituitary cell membrane. Molec. Endocrinol. 1, 283-293.